Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting.

Name: National Committee on Vital and Health Statistics (NCVHS).

Time and Date: November 27, 2007 9 a.m.3:45 p.m. November 28, 2007 10 a.m.3 p.m.

Place: Hilton Embassy Row Hotel, 2015 Massachusetts Avenue NW., Washington, DC, 2022651600.

Status: Open.

Purpose: At this meeting the Committee will hear presentations and hold discussions on several health data policy topics. On the morning and afternoon of the first day the Committee will hear updates from the Department and status reports from its
subcommittees as well as a presentation from the Robert Graham Center on harmonizing primary care standards.

On the morning of the second day the Committee will hear an update from the Office of the National Coordinator for Health Information Technology (ONCHIT) followed by Committee actions on selected topics from the subcommittee ]]> http://thefederalregister.com/d.p/2007-11-30-07-5876 Fri, Nov 30 2007 11:00:00 GMT http://thefederalregister.com/d.p/2007-11-30-E7-23234 http://cerhr.niehs.nih.gov) or in print from CERHR (see ADDRESSES below). The expert panel report is an evaluation of the reproductive and developmental toxicity of bisphenol A conducted by an independent, 12member expert panel composed of scientists from the public and private sectors convened by CERHR. CERHR invites the submission of public comments on this report (see SUPPLEMENTARY INFORMATION below). The expert panel met twice in public session (March 57, 2007 and August 68, 2007) to review and revise the draft expert panel report and reach conclusions regarding whether exposure to bisphenol A is a hazard to human development or reproduction. The expert panel also identified data gaps and research needs. ]]> http://thefederalregister.com/d.p/2007-11-30-E7-23234 Fri, Nov 30 2007 11:00:00 GMT http://thefederalregister.com/d.p/2007-11-30-07-5884

Amendment: Whereas, the H7 and H9 subtypes of avian influenza viruses are viewed as likely candidates to evolve into an influenza virus strain capable of causing a pandemic of human influenza; and

Whereas, in accordance with section 319F3(b)(6) of the Public Health Service Act (42 U.S.C. 247d6d(b)) (``the Act''), I have considered the desirability of encouraging the design, development, clinical testing or investigation, manufacturing and product formulation, labeling, distribution, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing, and use of these additional medical countermeasures with respect to the category of diseases and populatio ]]> http://thefederalregister.com/d.p/2007-11-30-07-5884 Fri, Nov 30 2007 11:00:00 GMT